MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,217,000 | -61.6% | 14,800 | -31.5% | 0.01% | -57.6% |
Q4 2021 | $3,169,000 | -5.2% | 21,600 | +14.3% | 0.03% | -2.9% |
Q3 2021 | $3,344,000 | +183.6% | 18,900 | +158.9% | 0.03% | +183.3% |
Q2 2021 | $1,179,000 | -29.8% | 7,300 | -25.5% | 0.01% | -33.3% |
Q1 2021 | $1,679,000 | -37.9% | 9,800 | -20.3% | 0.02% | -41.9% |
Q4 2020 | $2,702,000 | -8.6% | 12,300 | -30.9% | 0.03% | -24.4% |
Q3 2020 | $2,956,000 | +45.5% | 17,800 | 0.0% | 0.04% | +41.4% |
Q2 2020 | $2,032,000 | +66.3% | 17,800 | +11.9% | 0.03% | +20.8% |
Q1 2020 | $1,222,000 | -41.8% | 15,900 | -2.5% | 0.02% | -27.3% |
Q4 2019 | $2,100,000 | +69.5% | 16,300 | +2.5% | 0.03% | +43.5% |
Q3 2019 | $1,239,000 | -44.1% | 15,900 | -26.0% | 0.02% | -39.5% |
Q2 2019 | $2,215,000 | +108.4% | 21,500 | +48.3% | 0.04% | -34.5% |
Q1 2019 | $1,063,000 | +4.4% | 14,500 | -39.6% | 0.06% | -13.4% |
Q4 2018 | $1,018,000 | -13.6% | 24,000 | -4.0% | 0.07% | -10.7% |
Q3 2018 | $1,178,000 | -6.3% | 25,000 | -2.0% | 0.08% | -29.9% |
Q2 2018 | $1,257,000 | – | 25,500 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |